Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
06/2005
06/30/2005WO2005058830A1 Novel herbicides
06/30/2005WO2005058820A1 A synthetic methodology for the reductive alkylation at the c-3 position of indoles
06/30/2005WO2005058808A1 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof
06/30/2005WO2005058311A1 Heterocyclic aspartyl protease inhibitors
06/30/2005WO2005058037A1 Picolinylpyrazoles as herbicides
06/30/2005WO2005058035A1 Use of (3-(1-(3-phenyl-propenyl)-piperidin-4-yl)-2,3-dihydro-indol-1-yl)-(pyridin-4-yl)-methanone derivatives and related compounds as insecticides
06/30/2005WO2005034952A3 Isoxazole and isothiazole compounds useful in the treatment of inflammation
06/30/2005WO2005032493A8 Amide compounds as ion channel ligands and uses thereof
06/30/2005WO2005020899A3 Substituted cycloalkyamine derivatives as modulators of chemokine receptor activity
06/30/2005WO2005012914A3 Method for characterising polypeptides by maldi-tof mas spectrometry
06/30/2005WO2005000852A3 Product containing at least one phosphatase cdc25 inhibitor combined with at least one other anticancer agent
06/30/2005WO2004100960A8 Anti-inflammatory phosphonate compounds
06/30/2005WO2004096236A3 Immunomodulator phosphonate conjugates
06/30/2005WO2002058698A8 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
06/30/2005US20050143438 N3 alkylated benzimidazole derivatives as MEk inhibitors
06/30/2005US20050143436 N-acylamino with fused nitrogen heterocyclic ring compound; capase enzyme inhibitors; antiinflammatory agents; oral bioavailability; autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, degenerative diseases, and necrotic diseases
06/30/2005US20050143427 treating bone disorders of joint cartilage damage, osteoarthritis, rheumatoid arthritis, or joint inflammation, and pain associate with; antiinflammatory agent; 1-methyl-octahydroindole-2-carboxylic acid
06/30/2005US20050143422 N-({4'-[(1-benzofuran-2-ylcarbonyl)amino]-1,1'-biphenyl-4-yl}sulfonyl)glycine; metalloproteinase inhibitors; arthritis, macular degeneration, graft versus host disease, cancer, osteoarthritis
06/30/2005US20050143421 Substituted piperidino phenyloxazolidinones having antimicrobial activity with improved in vivo efficacy
06/30/2005US20050143418 Pesticidal heterocycles
06/30/2005US20050143376 Antimicrobial dihydrothiazine and dihydrothiopyran oxazolidinones
06/30/2005US20050143372 Compounds, pharmaceutical compositions and methods of use therefor
06/30/2005US20050143316 Hepatitis C virus inhibitors
06/30/2005US20050139814 Benzofuran and benzothiophene derivatives useful in the treatmint of hyper-proliferative disorders
06/30/2005DE10354584A1 Kationische Diaminopyrazole, ein Verfahren zu deren Herstellung und diese Verbindungen enthaltende Färbemittel Cationic diaminopyrazoles, a process for their preparation and compositions containing these compounds colorant
06/30/2005CA2550012A1 Urea derivative, process for producing the same and use
06/30/2005CA2549825A1 N-(4-carbamimidoyl-benzyl) -2-alkoxy-2-heterocyclyl acetamides as inhibitors of the formation of coagulation factors xa, ixa and thrombin induced by factor viia
06/30/2005CA2549660A1 Cyclopropane compounds and pharmaceutical use thereof
06/30/2005CA2549598A1 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof
06/30/2005CA2548571A1 Diacylhydrazine derivatives
06/30/2005CA2548393A1 Chemokine receptor binding compounds
06/30/2005CA2548388A1 Heterocyclic aspartyl protease inhibitors
06/30/2005CA2547600A1 Novel herbicides
06/30/2005CA2547518A1 Quinolines useful in treating cardiovascular disease
06/30/2005CA2547198A1 (3,4-disubstituted)propanoic carboxylates as s1p (edg) receptor agonists
06/29/2005EP1548011A1 Benzo[1,4]diazepin-2-one derivatives as phosphodiesterase PDE2 inhibitors, preparation and therapeutic use thereof
06/29/2005EP1548005A1 Process for producing 2-substituted pyridine derivative
06/29/2005EP1547996A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein
06/29/2005EP1546359A2 Site-specific labeling of affinity tags in fusion proteins
06/29/2005EP1546162A2 Luminescence-based methods and probes for measuring cytochrome p450 activity
06/29/2005EP1546145A1 Heterocyclic substituted piperazines for the treatment of schizophrenia
06/29/2005EP1546144A2 Delta1 pyrrolines used as pesticides
06/29/2005EP1546143A1 Heterocyclic substituted piperazines for the treatment of schizophrenia
06/29/2005EP1546142A2 Indoles having anti-diabetic activity
06/29/2005EP1546141A1 Isoxazoles and their use in the treatment of ischemic diseases
06/29/2005EP1546140A2 Antimicrobial oxazolidinones, process of their preparation, and pharmaceutical compositions containing them
06/29/2005EP1546116A1 Vanilloid receptor ligands and their use in treatments
06/29/2005EP1546113A1 Pyrimidinone derivatives as therapeutic agents against acute and chronic inflammatory, ischaemic and remodelling processes
06/29/2005EP1546099A2 3,6-disubstituted azabicyclo 3.1.0 hexane derivatives useful as muscarinic receptor antagonists
06/29/2005EP1546089A2 Aryl and heteroaryl compounds and methods to modulate coagulation
06/29/2005EP1545710A2 Therapeutic use
06/29/2005EP1545543A2 Novel tyrosine kinases inhibitors
06/29/2005EP1545538A2 N-biarylmethyl aminocycloalkanecarboxamide derivatives
06/29/2005EP1545532A2 Heterocyclic compounds
06/29/2005EP1545526A2 Removal of aldehyde impurity by reactive polystyrene resin
06/29/2005EP1545523A1 3-&-grave;(HETERO) ARYLMETHOXY ! PYRIDINES AND THEIR ANALOGUES ASP38 MAP KINASE INHIBITORS
06/29/2005EP1545517A1 Oxazolidin-2-one and thiazolidin-2-one derivatives for use as ep4 receptor agonists in the treatment of glaucoma
06/29/2005EP1545502A2 Keto cannabinoids with therapeutic indications
06/29/2005EP1274701B1 [1,4']-bipiperidine compounds
06/29/2005CN1633433A N-aroyl cyclic amines
06/29/2005CN1633429A 1-phenyl-2-heteroaryl-substituted benzimdazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives
06/29/2005CN1633428A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
06/29/2005CN1633419A CDK-inhibitory pyrimidines, their production and use as pharmaceutical agents
06/29/2005CN1633414A Chemical compounds
06/29/2005CN1633297A Acylated piperidine derivatives as melanocortin-4 receptor agonists
06/29/2005CN1633292A Cotherapy with an oxazolidinone and a vitamin B
06/29/2005CN1633291A 2-oxazolamines and their use as 5-ht2b receptor antagonists
06/29/2005CN1633290A Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
06/29/2005CN1631889A 3(2H)-pyridazinone derivative and its preparing process and application
06/29/2005CN1208321C Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
06/29/2005CN1208319C 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
06/29/2005CN1208318C Cycloamine CCR5 receptor antagonists
06/28/2005US6911549 Method of preparing a taxol derivative
06/28/2005US6911548 Method for the preparation of 5-cyanophthalide
06/28/2005US6911464 N-alkyl-hydroxamic acid-isoindolyl compounds and their pharmaceutical uses
06/28/2005US6911461 For treating epilepsy, epileptogenesis, seizure disorders, convulsions, bipolar disorders, mania, depression, anxiety, migraine, neuralgia, chronic pain, neuropathic pain, cerebral ischemia, cardiac arrhythmia, myotonia, cocaine abuse
06/28/2005US6911448 Piperazine and piperidine compounds
06/28/2005US6911444 Non-steroidal IL-5 inhibitors, processes and intermediates for their preparation and pharmaceutical compositions comprising said inhibitors
06/28/2005US6911439 Alpha 4 beta 1 integrin and CD49d/ CD29 (vla-4); antiinflammatory agents
06/28/2005CA2259977C Taxane derivatives and drugs containing the same
06/28/2005CA2114746C Substituted triazolinones
06/23/2005WO2005056550A2 Heterocyclic anti-migraine agents
06/23/2005WO2005056547A2 Quinoxalines useful as inhibitors of protein kinases
06/23/2005WO2005056538A1 Oxazole derivatives of tetracyclines
06/23/2005WO2005056537A1 The glucagon-like peptide-1 receptor agonists, the preparation and the use of the same
06/23/2005WO2005056535A1 1,2,3-triazole amide derivatives as inhibitors of cytokine production
06/23/2005WO2005056533A1 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament
06/23/2005WO2005056015A1 Substituted piperazines
06/23/2005WO2005056004A1 N-alkyl pyrroles as hmg-coa reductase inhibitors
06/23/2005WO2005056003A1 Dpp-iv inhibitors
06/23/2005WO2005055941A2 Novel m3 muscarinic acetylcholine receptor antagonists
06/23/2005WO2005055940A2 Novel m3 muscarinic acetylcholine receptor antagonists
06/23/2005WO2005055715A2 Insecticidal n-(heteroarylalkyl) alkanediamine derivatives
06/23/2005WO2005041888A3 Pyrimidin-4-one compounds, compositions and methods
06/23/2005WO2005040129A3 Ccr3 receptor antagonists
06/23/2005WO2005034870A3 Amide compounds and ion channel ligands and uses thereof
06/23/2005WO2005033930A3 Process for upgrading naphtha
06/23/2005WO2005025555A3 Combinations of an aryl aniline beta-2 adrenergic receptor agonist and a corticosteroid
06/23/2005WO2004052366A9 2-aminocarbonyl-quinoline compounds as platelet adenosine diphosphate receptor antagonists
06/23/2005US20050137399 A lithium-free reaction to produce a substituted/unsubstituted 4-amino-3-benzimidazol-2-yl-quinolin-2-one compound by reacting a 2-aminobenzonitrile with a 2-alkyloxycarbonylmethyl-benzimidazole in a solvent in the presence of a sodium or potassium salt of a base; excellent yields
1 ... 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 ... 647